John Drayton Wise - Jan 5, 2023 Form 4 Insider Report for INSMED Inc (INSM)

Signature
/s/ John Drayton Wise, by Michael Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
Jan 5, 2023
Transactions value $
-$22,898
Form type
4
Date filed
1/6/2023, 03:30 PM
Previous filing
Nov 22, 2022
Next filing
Jan 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Sale -$22.9K -1.16K -1.62% $19.74 70.5K Jan 5, 2023 Direct F1
transaction INSM Common Stock Award +7.6K +10.78% 78.1K Jan 5, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Award $0 +34.9K $0.00 34.9K Jan 5, 2023 Common Stock 34.9K $19.74 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2 Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.
F3 Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.
F4 Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.